CompuGroup Medical SE & C... (CMPVF)

PNK: CMPVF · Real-Time Price · USD

23.85

0.10 (0.42%)

At close: May 01, 2025, 8:00 PM

Compu Medical SE & KGaA Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	308.69M	283.44M	296.95M	307.11M	338.76M	302.03M	331.78M	315.22M	350.67M	279.69M	277.77M	278.46M	317.36M	320M	285.6M	269.07M
Cost of Revenue	54.31M	45.29M	203.94M	227.46M	283.41M	222.8M	234.88M	223.21M	250.02M	203.37M	209.77M	209.49M	242.84M	222.66M	215.54M	205.54M
Gross Profit	254.38M	238.15M	93.01M	79.65M	55.35M	79.23M	96.9M	92.01M	100.66M	76.31M	68M	68.97M	74.52M	97.33M	70.06M	63.53M
Operating Income	34.71M	n/a	28.62M	37.29M	34.62M	34.07M	57.99M	35.8M	45.88M	31.19M	22.29M	22.96M	26.09M	58.31M	39.04M	20.71M
Interest Income	78K	n/a	145.57K	256K	609K	120.51K	187.61K	173.41K	n/a	147K	120.52K	136.1K	3.65M	83.88K	698.5K	188.05K
Pretax Income	3.61M	12.27M	21.14M	28.35M	-21.36M	26.21M	49.87M	22.63M	20.44M	42.5M	19.07M	29.06M	19.37M	46.12M	29.53M	18.89M
Net Income	-6.47M	8.62M	13.93M	18.52M	-17.55M	15.95M	31.49M	14.38M	13.8M	28.75M	12.65M	20.15M	14.13M	32.88M	20.35M	12.9M
Selling & General & Admin	n/a	n/a	50.47M	49.56M	31.01M	49.68M	54.19M	57.6M	65.4M	47.14M	52.32M	47.25M	66M	40.97M	37.24M	45.63M
Research & Development	n/a	n/a	n/a	n/a	17.03M	4.24M	3.92M	n/a	4.34M	3.82M	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	219.67M	238.15M	7.55M	7.21M	10.28M	4.52M	15.28M	1.38M	10.62M	2.01M	6.61M	1.23M	17.56M	1.95M	6.23M	2.81M
Operating Expenses	219.67M	238.15M	234.58M	42.35M	20.73M	45.16M	38.92M	56.22M	54.78M	45.12M	45.71M	46.01M	48.44M	39.02M	31.01M	42.82M
Interest Expense	2.71M	14.48M	8.44M	7.7M	4.93M	9.2M	7.39M	6.24M	1.88M	3M	2.35M	2.49M	4.58M	2.58M	2.44M	1.55M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	273.98M	283.44M	268.33M	269.82M	304.15M	267.96M	273.79M	279.42M	304.8M	248.5M	255.48M	255.5M	291.28M	261.69M	246.55M	248.36M
Income Tax Expense	9.65M	3.68M	6.34M	8.51M	-3.58M	8.48M	15.96M	6.93M	5.03M	13.62M	6.37M	8.87M	5.23M	13.25M	9.15M	5.97M
Shares Outstanding (Basic)	51.71M	51.71M	51.71M	52.23M	52.23M	52.23M	52.23M	52.23M	52.23M	52.23M	52.23M	52.24M	52.59M	52.88M	52.88M	53.63M
Shares Outstanding (Diluted)	51.71M	51.71M	51.71M	52.23M	52.23M	52.24M	52.3M	52.26M	52.44M	52.23M	52.23M	52.24M	52.59M	55.61M	54.87M	56.06M
EPS (Basic)	-0.13	0.17	0.29	0.38	-0.34	0.32	0.66	0.30	0.28	0.55	0.24	0.39	0.27	0.62	0.38	0.24
EPS (Diluted)	-0.13	0.17	0.29	0.38	-0.34	0.32	0.66	0.30	0.28	0.55	0.24	0.39	0.27	0.59	0.37	0.23
EBITDA	35.68M	54.09M	56.07M	65.27M	27.62M	62.93M	78.02M	52.4M	58.78M	73.11M	46.28M	55.53M	59.11M	80.22M	60.85M	44.01M
EBIT	6.33M	26.75M	27.61M	36.66M	-13.8M	34.65M	56.64M	28.27M	25.95M	45.38M	21.11M	31.33M	22.89M	41.47M	26.3M	20.23M
Depreciation & Amortization	29.35M	27.33M	28.45M	28.61M	40.43M	28.28M	28.47M	28.52M	32.83M	27.72M	27.39M	30.12M	36.22M	31.85M	29.08M	31.53M